We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.68%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$19.1B
AUM Growth
+$1.76B
Cap. Flow
+$154M
Cap. Flow %
0.81%
Top 10 Hldgs %
32.12%
Holding
703
New
28
Increased
257
Reduced
281
Closed
39

Top Buys

Rank Stock Value
1
NU icon
Nu Holdings
NU
+$60.7M
2
JNJ icon
Johnson & Johnson
JNJ
+$58.3M
3
SCHW
Charles Schwab
SCHW
+$54M
4
ABBV icon
AbbVie
ABBV
+$52.9M
5
PANW icon
Palo Alto Networks
PANW
+$42.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$92.7M
2
EMR icon
Emerson Electric
EMR
+$57.2M
3
MELI icon
Mercado Libre
MELI
+$48.9M
4
AVGO icon
Broadcom
AVGO
+$38.9M
5
MU icon
Micron Technology
MU
+$37.7M

Sector Composition

Rank Sector Weight
1 Technology 36.63%
2 Healthcare 23.08%
3 Financials 11.48%
4 Consumer Discretionary 7.78%
5 Communication Services 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
101
HCA Healthcare
HCA
$86.4B
$42.2M 0.22%
99,102
-62,538
-39% -$24.2M
LAUR icon
102
Laureate Education
LAUR
$5.25B
$41.9M 0.22%
1,329,851
+115,151
+9% +$3.02M
CGON icon
103
CG Oncology
CGON
$6.48B
$41.8M 0.22%
1,037,892
+274,312
+36% +$7.97M
PYPL icon
104
PayPal
PYPL
$49.5B
$41.8M 0.22%
623,059
+536,452
+619% +$37.8M
WDC icon
105
Western Digital
WDC
$172B
$41.6M 0.22%
346,141
+315,207
+1,019% +$25.8M
RL icon
106
Ralph Lauren
RL
$22.6B
$41.3M 0.22%
131,817
+36,830
+39% +$11M
RVMD icon
107
Revolution Medicines
RVMD
$40B
$40.6M 0.21%
868,724
+149,211
+21% +$5.84M
BMY icon
108
Bristol-Myers Squibb
BMY
$128B
$40.5M 0.21%
897,263
-105,641
-11% -$4.93M
NBIX icon
109
Neurocrine Biosciences
NBIX
$17.7B
$40.4M 0.21%
287,645
-10,906
-4% -$1.48M
IONS icon
110
Ionis Pharmaceuticals
IONS
$9.25B
$40M 0.21%
611,237
-113,503
-16% -$5.54M
DDOG icon
111
Datadog
DDOG
$89.7B
$38.8M 0.2%
272,170
+68,597
+34% +$9.45M
CTAS icon
112
Cintas
CTAS
$84.4B
$36.9M 0.19%
179,586
-118,621
-40% -$25.3M
AEM icon
113
Agnico Eagle Mines
AEM
$73B
$36.8M 0.19%
218,303
+45,585
+26% +$6.26M
MDLZ icon
114
Mondelez International
MDLZ
$77.9B
$36.8M 0.19%
588,417
-250,528
-30% -$16.2M
AMAT icon
115
Applied Materials
AMAT
$410B
$36.7M 0.19%
179,467
-102,015
-36% -$18.5M
EGO icon
116
Eldorado Gold
EGO
$8.48B
$36.7M 0.19%
1,270,400
+97,900
+8% +$2.3M
XOM icon
117
ExxonMobil
XOM
$642B
$35.9M 0.19%
318,725
+8,300
+3% +$923K
PNC icon
118
PNC Financial Services
PNC
$99.6B
$35.9M 0.19%
178,811
+13,321
+8% +$2.63M
ASND icon
119
Ascendis Pharma A/S
ASND
$16.6B
$35.6M 0.19%
178,956
-16,159
-8% -$3.01M
ARGX icon
120
argenx
ARGX
$55.6B
$35.6M 0.19%
48,200
+2,633
+6% +$1.74M
BLK icon
121
Blackrock
BLK
$165B
$35.4M 0.19%
30,373
+9,806
+48% +$11M
MELI icon
122
Mercado Libre
MELI
$92.3B
$35M 0.18%
14,958
-20,354
-58% -$48.9M
FSLR icon
123
First Solar
FSLR
$22.1B
$33.2M 0.17%
150,379
+62,048
+70% +$11.9M
MTD icon
124
Mettler-Toledo International
MTD
$27B
$33.2M 0.17%
27,007
-3,184
-11% -$3.99M
ROIV icon
125
Roivant Sciences
ROIV
$25B
$32.7M 0.17%
2,157,995
+654,001
+43% +$8.1M
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2025 Portfolio in Review

As of Q3 2025, Candriam SCA held 703 positions worth $19.1B, up 10% from $17.3B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q3 2025 filing shows 28 new, 257 increased, 281 reduced and 39 closed positions. Its largest new stake was Banco Macro: 322,600 shares worth $13.6M. The largest sale was NVIDIA, an estimated $92.7M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2025 buy was Banco Macro: 322,600 shares worth $13.6M.
  • Candriam SCA added most to Nu Holdings in Q3 2025, an estimated $60.7M increase.
  • Candriam SCA's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $92.7M.
  • Candriam SCA fully exited Verona Pharma in Q3 2025, selling an estimated $20.5M.
  • Candriam SCA's ten largest holdings make up 32% of its $19.1B portfolio in Q3 2025.
  • Candriam SCA opened 28 new positions and closed 39 in Q3 2025.
  • Candriam SCA's portfolio value rose 10% quarter-over-quarter to $19.1B.

Based on Candriam SCA's 13F filing for Q3 2025, filed 6 Nov 2025.